位置:首页 > 蛋白库 > MAP11_HUMAN
MAP11_HUMAN
ID   MAP11_HUMAN             Reviewed;         386 AA.
AC   P53582; B4E2E6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2003, sequence version 2.
DT   03-AUG-2022, entry version 210.
DE   RecName: Full=Methionine aminopeptidase 1 {ECO:0000255|HAMAP-Rule:MF_03174};
DE            Short=MAP 1 {ECO:0000255|HAMAP-Rule:MF_03174};
DE            Short=MetAP 1 {ECO:0000255|HAMAP-Rule:MF_03174};
DE            EC=3.4.11.18 {ECO:0000255|HAMAP-Rule:MF_03174};
DE   AltName: Full=Peptidase M 1 {ECO:0000255|HAMAP-Rule:MF_03174};
GN   Name=METAP1; Synonyms=KIAA0094;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=7788527; DOI=10.1093/dnares/2.1.37;
RA   Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S., Tabata S.,
RA   Ishikawa K., Kawarabayasi Y., Kotani H., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. III. The
RT   coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:37-43(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 110-386.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 81-384 IN COMPLEX WITH COBALT
RP   IONS, FUNCTION, AND COFACTOR.
RX   PubMed=16274222; DOI=10.1021/bi051691k;
RA   Addlagatta A., Hu X., Liu J.O., Matthews B.W.;
RT   "Structural basis for the functional differences between type I and type II
RT   human methionine aminopeptidases.";
RL   Biochemistry 44:14741-14749(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 81-384 IN COMPLEX WITH COBALT IONS
RP   AND INHIBITORS.
RX   PubMed=16724298; DOI=10.1002/anie.200600757;
RA   Hu X., Addlagatta A., Matthews B.W., Liu J.O.;
RT   "Identification of pyridinylpyrimidines as inhibitors of human methionine
RT   aminopeptidases.";
RL   Angew. Chem. Int. Ed. 45:3772-3775(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 81-384 IN COMPLEX WITH COBALT IONS
RP   AND INHIBITORS, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=17114291; DOI=10.1073/pnas.0608389103;
RA   Hu X., Addlagatta A., Lu J., Matthews B.W., Liu J.O.;
RT   "Elucidation of the function of type 1 human methionine aminopeptidase
RT   during cell cycle progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18148-18153(2006).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 81-384 IN COMPLEX WITH COBALT IONS
RP   AND THE INHIBITOR OVALICIN.
RX   PubMed=16823043; DOI=10.1110/ps.062278006;
RA   Addlagatta A., Matthews B.W.;
RT   "Structure of the angiogenesis inhibitor ovalicin bound to its noncognate
RT   target, human Type 1 methionine aminopeptidase.";
RL   Protein Sci. 15:1842-1848(2006).
CC   -!- FUNCTION: Cotranslationally removes the N-terminal methionine from
CC       nascent proteins. The N-terminal methionine is often cleaved when the
CC       second residue in the primary sequence is small and uncharged (Met-
CC       Ala-, Cys, Gly, Pro, Ser, Thr, or Val). Required for normal progression
CC       through the cell cycle. {ECO:0000255|HAMAP-Rule:MF_03174,
CC       ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:17114291}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Release of N-terminal amino acids, preferentially methionine,
CC         from peptides and arylamides.; EC=3.4.11.18;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:17114291};
CC   -!- COFACTOR:
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
CC         ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291};
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174};
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174};
CC       Note=Binds 2 divalent metal cations per subunit. Has a high-affinity
CC       and a low affinity metal-binding site. The true nature of the
CC       physiological cofactor is under debate. The enzyme is active with
CC       cobalt, zinc, manganese or divalent iron ions. Most likely, methionine
CC       aminopeptidases function as mononuclear Fe(2+)-metalloproteases under
CC       physiological conditions, and the catalytically relevant metal-binding
CC       site has been assigned to the histidine-containing high-affinity site.
CC       {ECO:0000255|HAMAP-Rule:MF_03174};
CC   -!- SUBUNIT: Associates with the 60S ribosomal subunit of the 80S
CC       translational complex. {ECO:0000255|HAMAP-Rule:MF_03174}.
CC   -!- INTERACTION:
CC       P53582; O76003: GLRX3; NbExp=3; IntAct=EBI-1051435, EBI-374781;
CC       P53582; Q0VD86: INCA1; NbExp=3; IntAct=EBI-1051435, EBI-6509505;
CC       P53582; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-1051435, EBI-16439278;
CC       P53582; Q14596-2: NBR1; NbExp=3; IntAct=EBI-1051435, EBI-11081753;
CC       P53582; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-1051435, EBI-949255;
CC       P53582; Q9UGI0: ZRANB1; NbExp=4; IntAct=EBI-1051435, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03174}.
CC   -!- SIMILARITY: Belongs to the peptidase M24A family. Methionine
CC       aminopeptidase type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_03174}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH30054.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA07679.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D42084; BAA07679.1; ALT_INIT; mRNA.
DR   EMBL; AK304239; BAG65108.1; -; mRNA.
DR   EMBL; CH471057; EAX06083.1; -; Genomic_DNA.
DR   EMBL; BC030054; AAH30054.1; ALT_INIT; mRNA.
DR   CCDS; CCDS47110.1; -.
DR   RefSeq; NP_055958.2; NM_015143.2.
DR   PDB; 2B3H; X-ray; 1.10 A; A=81-384.
DR   PDB; 2B3K; X-ray; 1.55 A; A=81-384.
DR   PDB; 2B3L; X-ray; 1.50 A; A=81-384.
DR   PDB; 2G6P; X-ray; 1.90 A; A=81-384.
DR   PDB; 2GZ5; X-ray; 1.10 A; A=81-384.
DR   PDB; 2NQ6; X-ray; 1.50 A; A=81-384.
DR   PDB; 2NQ7; X-ray; 1.60 A; A=81-384.
DR   PDB; 4FLI; X-ray; 1.55 A; A=81-386.
DR   PDB; 4FLJ; X-ray; 1.74 A; A=81-386.
DR   PDB; 4FLK; X-ray; 1.47 A; A=81-386.
DR   PDB; 4FLL; X-ray; 1.50 A; A=81-386.
DR   PDB; 4HXX; X-ray; 2.09 A; A=81-384.
DR   PDB; 4IKR; X-ray; 1.78 A; A=81-384.
DR   PDB; 4IKS; X-ray; 1.70 A; A=81-384.
DR   PDB; 4IKT; X-ray; 1.60 A; A=81-384.
DR   PDB; 4IKU; X-ray; 1.30 A; A=81-384.
DR   PDB; 4IU6; X-ray; 1.90 A; A=1-384.
DR   PDB; 4U1B; X-ray; 1.89 A; A=81-386.
DR   PDB; 4U69; X-ray; 1.60 A; A=81-386.
DR   PDB; 4U6C; X-ray; 1.91 A; A=81-386.
DR   PDB; 4U6E; X-ray; 1.90 A; A=81-386.
DR   PDB; 4U6J; X-ray; 1.56 A; A=81-386.
DR   PDB; 4U6W; X-ray; 1.83 A; A=81-386.
DR   PDB; 4U6Z; X-ray; 1.80 A; A=81-386.
DR   PDB; 4U70; X-ray; 1.60 A; A=81-386.
DR   PDB; 4U71; X-ray; 1.80 A; A=81-386.
DR   PDB; 4U73; X-ray; 1.80 A; A=81-386.
DR   PDB; 4U75; X-ray; 1.94 A; A=81-386.
DR   PDB; 4U76; X-ray; 1.87 A; A=81-386.
DR   PDB; 5YKP; X-ray; 1.68 A; A=81-384.
DR   PDB; 5YR4; X-ray; 1.82 A; A=81-384.
DR   PDB; 5YR5; X-ray; 1.60 A; A=81-384.
DR   PDB; 5YR6; X-ray; 1.75 A; A=81-384.
DR   PDB; 5YR7; X-ray; 2.06 A; A=81-386.
DR   PDB; 6LZB; X-ray; 1.29 A; A=81-384.
DR   PDB; 6LZC; X-ray; 1.35 A; A=81-384.
DR   PDBsum; 2B3H; -.
DR   PDBsum; 2B3K; -.
DR   PDBsum; 2B3L; -.
DR   PDBsum; 2G6P; -.
DR   PDBsum; 2GZ5; -.
DR   PDBsum; 2NQ6; -.
DR   PDBsum; 2NQ7; -.
DR   PDBsum; 4FLI; -.
DR   PDBsum; 4FLJ; -.
DR   PDBsum; 4FLK; -.
DR   PDBsum; 4FLL; -.
DR   PDBsum; 4HXX; -.
DR   PDBsum; 4IKR; -.
DR   PDBsum; 4IKS; -.
DR   PDBsum; 4IKT; -.
DR   PDBsum; 4IKU; -.
DR   PDBsum; 4IU6; -.
DR   PDBsum; 4U1B; -.
DR   PDBsum; 4U69; -.
DR   PDBsum; 4U6C; -.
DR   PDBsum; 4U6E; -.
DR   PDBsum; 4U6J; -.
DR   PDBsum; 4U6W; -.
DR   PDBsum; 4U6Z; -.
DR   PDBsum; 4U70; -.
DR   PDBsum; 4U71; -.
DR   PDBsum; 4U73; -.
DR   PDBsum; 4U75; -.
DR   PDBsum; 4U76; -.
DR   PDBsum; 5YKP; -.
DR   PDBsum; 5YR4; -.
DR   PDBsum; 5YR5; -.
DR   PDBsum; 5YR6; -.
DR   PDBsum; 5YR7; -.
DR   PDBsum; 6LZB; -.
DR   PDBsum; 6LZC; -.
DR   AlphaFoldDB; P53582; -.
DR   SMR; P53582; -.
DR   BioGRID; 116785; 39.
DR   IntAct; P53582; 23.
DR   MINT; P53582; -.
DR   STRING; 9606.ENSP00000296411; -.
DR   BindingDB; P53582; -.
DR   ChEMBL; CHEMBL2474; -.
DR   DrugBank; DB07903; 3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE.
DR   DrugBank; DB07901; 5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE.
DR   DrugBank; DB04324; Ovalicin.
DR   DrugBank; DB07902; TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE.
DR   DrugCentral; P53582; -.
DR   GuidetoPHARMACOLOGY; 1572; -.
DR   MEROPS; M24.017; -.
DR   GlyGen; P53582; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P53582; -.
DR   PhosphoSitePlus; P53582; -.
DR   SwissPalm; P53582; -.
DR   BioMuta; METAP1; -.
DR   DMDM; 33302602; -.
DR   EPD; P53582; -.
DR   jPOST; P53582; -.
DR   MassIVE; P53582; -.
DR   MaxQB; P53582; -.
DR   PaxDb; P53582; -.
DR   PeptideAtlas; P53582; -.
DR   PRIDE; P53582; -.
DR   ProteomicsDB; 56586; -.
DR   Antibodypedia; 25840; 204 antibodies from 25 providers.
DR   DNASU; 23173; -.
DR   Ensembl; ENST00000296411.11; ENSP00000296411.6; ENSG00000164024.12.
DR   GeneID; 23173; -.
DR   KEGG; hsa:23173; -.
DR   MANE-Select; ENST00000296411.11; ENSP00000296411.6; NM_015143.3; NP_055958.2.
DR   UCSC; uc003huf.5; human.
DR   CTD; 23173; -.
DR   DisGeNET; 23173; -.
DR   GeneCards; METAP1; -.
DR   HGNC; HGNC:15789; METAP1.
DR   HPA; ENSG00000164024; Low tissue specificity.
DR   MIM; 610151; gene.
DR   neXtProt; NX_P53582; -.
DR   OpenTargets; ENSG00000164024; -.
DR   PharmGKB; PA30764; -.
DR   VEuPathDB; HostDB:ENSG00000164024; -.
DR   eggNOG; KOG2738; Eukaryota.
DR   GeneTree; ENSGT00940000158205; -.
DR   HOGENOM; CLU_015857_2_1_1; -.
DR   InParanoid; P53582; -.
DR   OMA; GDHAYTF; -.
DR   OrthoDB; 1002357at2759; -.
DR   PhylomeDB; P53582; -.
DR   TreeFam; TF105753; -.
DR   BioCyc; MetaCyc:HS08982-MON; -.
DR   BRENDA; 3.4.11.18; 2681.
DR   PathwayCommons; P53582; -.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   SABIO-RK; P53582; -.
DR   SignaLink; P53582; -.
DR   BioGRID-ORCS; 23173; 452 hits in 1092 CRISPR screens.
DR   ChiTaRS; METAP1; human.
DR   EvolutionaryTrace; P53582; -.
DR   GeneWiki; METAP1; -.
DR   GenomeRNAi; 23173; -.
DR   Pharos; P53582; Tchem.
DR   PRO; PR:P53582; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P53582; protein.
DR   Bgee; ENSG00000164024; Expressed in esophagus squamous epithelium and 207 other tissues.
DR   ExpressionAtlas; P53582; baseline and differential.
DR   Genevisible; P53582; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:HGNC-UCL.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0004177; F:aminopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008235; F:metalloexopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0031365; P:N-terminal protein amino acid modification; TAS:HGNC-UCL.
DR   GO; GO:0018206; P:peptidyl-methionine modification; TAS:HGNC-UCL.
DR   GO; GO:0070527; P:platelet aggregation; HMP:UniProtKB.
DR   GO; GO:0035551; P:protein initiator methionine removal involved in protein maturation; IBA:GO_Central.
DR   GO; GO:0006417; P:regulation of translation; TAS:HGNC-UCL.
DR   CDD; cd01086; MetAP1; 1.
DR   Gene3D; 3.90.230.10; -; 1.
DR   HAMAP; MF_01974; MetAP_1; 1.
DR   InterPro; IPR036005; Creatinase/aminopeptidase-like.
DR   InterPro; IPR000994; Pept_M24.
DR   InterPro; IPR001714; Pept_M24_MAP.
DR   InterPro; IPR002467; Pept_M24A_MAP1.
DR   InterPro; IPR031615; Zfn-C6H2.
DR   Pfam; PF00557; Peptidase_M24; 1.
DR   Pfam; PF15801; zf-C6H2; 1.
DR   PRINTS; PR00599; MAPEPTIDASE.
DR   SUPFAM; SSF55920; SSF55920; 1.
DR   TIGRFAMs; TIGR00500; met_pdase_I; 1.
DR   PROSITE; PS00680; MAP_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Aminopeptidase; Cytoplasm; Hydrolase;
KW   Metal-binding; Protease; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..386
FT                   /note="Methionine aminopeptidase 1"
FT                   /id="PRO_0000148967"
FT   REGION          9..52
FT                   /note="Zinc finger-like; important for proper ribosome
FT                   association"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174"
FT   BINDING         203
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16724298, ECO:0000269|PubMed:16823043,
FT                   ECO:0000269|PubMed:17114291"
FT   BINDING         220
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   BINDING         231
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   BINDING         231
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   BINDING         294
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   BINDING         301
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16724298, ECO:0000269|PubMed:16823043,
FT                   ECO:0000269|PubMed:17114291"
FT   BINDING         327
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   BINDING         358
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   BINDING         358
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:16724298,
FT                   ECO:0000269|PubMed:16823043, ECO:0000269|PubMed:17114291"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           107..110
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           117..121
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   TURN            122..124
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           133..155
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           163..176
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   TURN            182..185
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           186..188
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          191..197
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          216..225
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          228..237
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           243..261
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           271..282
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          293..295
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          297..306
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          309..311
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          323..326
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          329..333
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          337..339
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          346..348
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          354..356
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          358..363
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   STRAND          365..370
FT                   /evidence="ECO:0007829|PDB:2B3H"
FT   HELIX           381..383
FT                   /evidence="ECO:0007829|PDB:2B3H"
SQ   SEQUENCE   386 AA;  43215 MW;  372879013C2BB01D CRC64;
     MAAVETRVCE TDGCSSEAKL QCPTCIKLGI QGSYFCSQEC FKGSWATHKL LHKKAKDEKA
     KREVSSWTVE GDINTDPWAG YRYTGKLRPH YPLMPTRPVP SYIQRPDYAD HPLGMSESEQ
     ALKGTSQIKL LSSEDIEGMR LVCRLAREVL DVAAGMIKPG VTTEEIDHAV HLACIARNCY
     PSPLNYYNFP KSCCTSVNEV ICHGIPDRRP LQEGDIVNVD ITLYRNGYHG DLNETFFVGE
     VDDGARKLVQ TTYECLMQAI DAVKPGVRYR ELGNIIQKHA QANGFSVVRS YCGHGIHKLF
     HTAPNVPHYA KNKAVGVMKS GHVFTIEPMI CEGGWQDETW PDGWTAVTRD GKRSAQFEHT
     LLVTDTGCEI LTRRLDSARP HFMSQF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024